Dr. Reddy's, Pfizer Settle Patent Suit Over Generic Of Lipitor
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories settled a suit with Pfizer, ending a case surrounding the patent protection for the best-selling anti-cholesterol drug Lipitor (atorvastatin)